Safety and Efficacy of Siponimod (BAF312) in Patients With Relapsing-Remitting Multiple Sclerosis: Dose-Blinded, Randomized Extension of the Phase 2 BOLD Study.
Kappos L, Li DKB, Stüve O, Hartung H-P, Freedman MS, Hemmer B, Rieckmann P, Montalban X, Ziemssen T, Hunter B, et al.
